Top 15 Companies in Global Cannabidiol (CBD) Consumer Health Market: Statistics Report Till 2035

Description

According to a research report published by Spherical Insights & Consulting, The Global Cannabidiol (CBD) Consumer Health Market Size Is Projected To Grow From USD 18.13 Billion In 2024 To USD 85.32 Billion By 2035, At A CAGR Of 15.12% During The Forecast Period 2024–2035.  The global cannabidiol (CBD) consumer health market is driven by the rising consumer awareness of wellness benefits, increasing legalization of hemp-derived products, and growing demand for natural alternatives to pharmaceuticals drive the CBD consumer health market. Expanding product innovation, e-commerce penetration, and endorsements for pain, anxiety, and sleep management further accelerate adoption, supported by evolving regulatory frameworks and increasing investment in research and development.

 

Introduction

The global cannabidiol (CBD) consumer health market refers to the production and commercialization of CBD-infused products derived primarily from hemp, used for wellness applications such as pain relief, anxiety management, sleep improvement, and general health support. These products include oils, capsules, topicals, edibles, and beverages, catering to a broad consumer base seeking plant-based alternatives. Cannabidiol (CBD) is a non-intoxicating, therapeutic compound derived from the hemp plant (Cannabis sativa).  It does not produce a high. It is used for potential wellness benefits like reducing anxiety, pain, and inflammation. Growth is driven by increasing consumer inclination toward natural remedies and expanding legalization frameworks. A detailed assessment highlights the evolving dynamics of CBD consumption patterns. Consumer data indicate that approximately 64% of users utilize CBD for pain management, while nearly 49% rely on it for anxiety relief, reflecting strong demand for alternative therapeutic solutions. The regulatory environment demonstrates progressive acceptance, with 47 out of 50 U.S. states permitting CBD usage to varying extents, indicating a broadly supportive yet fragmented legal framework. Furthermore, by 2024, an estimated 35% of the U.S. population is projected to have experimented with CBD products, underscoring the growing mainstream adoption of CBD within consumer health markets. Opportunities lie in product innovation, functional foods, and emerging markets, supported by regulatory evolution. The innovations are expanding into advanced delivery systems, with increasing focus on nano-formulated CBD designed to improve bioavailability and skin absorption in dermatological applications.

In December 2025, New legislative actions were passed with the aim of significantly restricting hemp-derived products, including certain CBD formulations, which could impact product availability, pricing, and interstate trade beginning in 2026.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global cannabidiol (CBD) consumer health market.

 

Market Segmentation

Global Cannabidiol (CBD) Consumer Health Market Size, Share, and, By Product Type (Oils & Tinctures, Capsules & Softgels, Topicals, Edibles & Beverages, and Others), By Source (Hemp-Derived and Marijuana-Derived), By Application (Pain Management, Anxiety & Stress Management, Sleep Disorders, General Wellness, and Others), By Distribution Channel (Online Stores, Retail Pharmacies, Hospital Pharmacies, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa), Analysis and Forecast 2024 – 2035.

 

Global Cannabidiol (CBD) Consumer Health Market Size & Statistics

• The market size for Global Cannabidiol (CBD) Consumer Health was estimated to be worth USD 18.13 billion in 2024.
• The market is going to expand at a CAGR of 15.12% between 2024 and 2035.
• The Global Cannabidiol (CBD) Consumer Health market size is anticipated to reach USD 85.32 billion by 2035.
• North America is expected to generate the largest revenue during the forecast period in the Global Cannabidiol (CBD) Consumer Health market
• Asia Pacific is expected to grow at the fastest rate during the forecast period in the Global Cannabidiol (CBD) Consumer Health market.

Regional growth and demand                                  

Asia Pacific is expected to grow at the fastest rate during the forecast period in the global cannabidiol (CBD) consumer health market. Asia Pacific is expected to grow at the fastest rate due to due to increasing awareness of plant-based wellness products and gradual regulatory easing in select countries. Expanding middle-class populations, rising disposable incomes, and growing interest in alternative therapies are accelerating demand. Additionally, increasing investments in hemp cultivation and CBD-based product development, particularly in countries such as Australia, Japan, and South Korea, are contributing to rapid market expansion.

 

North America is expected to generate the largest revenue during the forecast period in the global cannabidiol (CBD) consumer health market. North America is expected to generate the highest revenue, supported by early legalization, well-established supply chains, and strong consumer acceptance. The presence of major market players, advanced retail infrastructure, and widespread product availability across pharmacies and e-commerce platforms reinforce its dominance. Furthermore, high consumer awareness and continuous product innovation contribute to sustained market leadership in the region.

 

 

Top 10 Trends in The Global Cannabidiol (CBD) Consumer Health Market

• Expansion Of CBD-Infused Functional Foods and Beverages
• Rising Demand for Topical and Skincare Applications
• Growth In Pharmaceutical-Grade CBD And Clinical Research
• Increasing Adoption of Nano-Technology for Enhanced Bioavailability
• Expansion Of E-Commerce and Direct-To-Consumer Distribution Channels
• Regulatory Tightening and Standardization Efforts
• Product Diversification Targeting Specific Health Conditions
• Entry Of Established Consumer Health and Wellness Brands
• Increasing Focus on Sustainable and Organic Hemp Cultivation
• Growth In Emerging Markets with Evolving Legalization Framework

 

• Expansion of CBD-infused functional foods and beverages

The integration of CBD into functional foods and beverages is gaining traction as consumers seek convenient and non-invasive methods of consumption. Manufacturers are introducing CBD-infused drinks, gummies, and nutritional supplements designed to support relaxation, stress reduction, and overall wellness. This trend is supported by increasing acceptance of nutraceutical products and the growing preference for preventive healthcare. Additionally, companies are focusing on improving taste profiles and dosage consistency, making these products more appealing to a broader consumer base. Regulatory developments, however, continue to influence the pace of expansion across different regions.

 

• Rising demand for topical and skincare applications

CBD-based topical products are witnessing significant growth due to their perceived benefits in managing inflammation, pain, and various skin conditions. These products include creams, balms, lotions, and serums formulated for targeted application. The trend is further supported by the expansion of the cosmetics industry, where CBD is increasingly incorporated into anti-aging and therapeutic skincare formulations. Consumers are gravitating toward natural and plant-based ingredients, which enhances the appeal of CBD-infused products. Continuous innovation in formulations and improved product efficacy is expected to further drive the adoption of topical applications globally.

 

• Growth in pharmaceutical-grade CBD and clinical research

The CBD market is experiencing a shift toward pharmaceutical-grade products supported by scientific validation and clinical studies. Companies are increasingly investing in research to explore the therapeutic potential of CBD in treating conditions such as epilepsy, anxiety disorders, and chronic pain. This trend is driven by the need for standardized dosages, safety validation, and regulatory approvals. Pharmaceutical-grade CBD products are gaining credibility among healthcare professionals, which enhances their adoption in clinical settings. Continued research and collaboration with regulatory authorities are expected to expand the scope of CBD in mainstream medicine.

 

• Increasing adoption of nano-technology for enhanced bioavailability

Advancements in nano-technology are transforming CBD product formulations by improving absorption rates and bioavailability. Nano-emulsification techniques break down CBD particles into smaller sizes, enabling faster and more efficient delivery into the bloodstream. This innovation addresses one of the key challenges associated with traditional CBD products, which often have inconsistent absorption. Enhanced bioavailability allows manufacturers to offer products with improved efficacy at lower dosages. As a result, nano-based formulations are gaining popularity across various applications, including beverages, tinctures, and skincare products, contributing to overall market growth.

 

• Expansion of e-commerce and direct-to-consumer distribution channels

The rapid growth of e-commerce platforms has significantly influenced the distribution of CBD products worldwide. Online channels provide consumers with easy access to a wide variety of CBD products, detailed product information, and competitive pricing. Direct-to-consumer models enable companies to build stronger relationships with customers while maintaining better control over branding and quality assurance. This trend is particularly important in regions with limited physical retail availability. Additionally, digital marketing strategies and subscription-based models are enhancing customer engagement and driving repeat purchases, further strengthening the role of e-commerce in market expansion.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global cannabidiol (CBD) consumer health market.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global cannabidiol (CBD) consumer health market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 15 Companies Leading the Global cannabidiol (CBD) consumer health Market

1. Charlotte’s Web Holdings, Inc.
2. CV Sciences, Inc.
3. Medical Marijuana, Inc.
4. Elixinol Wellness Ltd
5. Medterra CBD, LLC
6. cbdMD, Inc.
7. NuLeaf Naturals, LLC
8. Green Roads LLC
9. CBD American Shaman
10. Lazarus Naturals
11. Folium Biosciences
12. Endoca
13. Joy Organics
14. PharmaHemp d.o.o.
15. Kazmira LLC

 

• Charlotte’s Web Holdings, Inc

Headquarters: Boulder, Colorado, USA

Charlotte’s Web Holdings, Inc., active in over 20 countries, is a leading player in the global CBD consumer health market, specializing in full-spectrum hemp-derived wellness products. The company offers a wide portfolio including oils, capsules, gummies, and topical solutions targeting stress, sleep, and recovery. It has established a strong retail and e-commerce presence, supported by vertically integrated operations from cultivation to distribution. With a focus on quality, transparency, and compliance, the company plays a significant role in shaping consumer trust and expanding the adoption of plant-based health products across international markets.

 

• CV Sciences, Inc.

Headquarters: San Diego, California, USA

CV Sciences, Inc., active in over 15 countries, is a prominent CBD company known for its +PlusCBD brand in the natural products retail channel. The company focuses on delivering hemp-derived supplements aimed at wellness, pain management, and mental health support. It has built a strong presence across pharmacies, health stores, and online platforms, supported by scientific research and product standardization. CV Sciences emphasizes regulatory compliance and consumer education, contributing to the credibility of CBD products in mainstream healthcare. Its expanding distribution network strengthens its position in the evolving global CBD consumer health landscape.

 

• Medical Marijuana, Inc.

Headquarters: San Diego, California, USA

Medical Marijuana, Inc., active in over 40 countries, is one of the earliest entrants in the CBD industry, offering a diverse range of hemp-based products through its subsidiaries. The company operates across nutraceuticals, cosmetics, and pharmaceutical segments, with a strong focus on international market penetration. Its vertically integrated business model supports cultivation, extraction, and product development. By leveraging its global distribution network and established brand portfolio, the company plays a key role in advancing CBD awareness and accessibility. It continues to expand its footprint through strategic partnerships and product innovation.

 

• Elixinol Wellness Ltd

Headquarters: Sydney, Australia

Elixinol Wellness Ltd, active in over 25 countries, is a global CBD company focused on delivering high-quality hemp-derived nutraceuticals and topical products. The company emphasizes scientifically formulated products targeting sleep, stress, and overall wellness. It operates through a diversified portfolio spanning supplements, skincare, and food products, supported by strong research and development capabilities. Elixinol maintains a robust international presence through both online and retail distribution channels. Its commitment to quality standards and sustainable sourcing practices strengthens its position as a reliable provider in the global CBD consumer health market.

 

• Medterra CBD, LLC

Headquarters: Irvine, California, USA

Medterra CBD, LLC, active in over 20 countries, is a well-recognized CBD brand offering a broad range of THC-free, hemp-derived wellness products. The company’s portfolio includes tinctures, capsules, topicals, and functional products designed for pain relief, sleep support, and daily wellness. Medterra has established a strong global presence through e-commerce platforms and retail partnerships. It focuses on product traceability, third-party testing, and compliance with regulatory standards. By delivering consistent quality and affordable solutions, the company contributes to the growing acceptance and accessibility of CBD products in the global consumer health market.

 

Are you ready to discover more about the global cannabidiol (CBD) consumer health market?

The report provides an in-depth analysis of the leading companies operating in the global cannabidiol (CBD) consumer health market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Charlotte’s Web Holdings, Inc

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. CV Sciences, Inc.
2. Medical Marijuana, Inc.
3. Elixinol Wellness Ltd
4. Medterra CBD, LLC
5. cbdMD, Inc.
6. NuLeaf Naturals, LLC
7. Green Roads LLC
8. CBD American Shaman
9. Others.

 

Conclusion

The global cannabidiol (CBD) consumer health market is witnessing steady growth, driven by increasing consumer preference for plant-based wellness solutions, expanding legalization frameworks, and growing awareness of therapeutic benefits. CBD products provide natural alternatives for pain management, anxiety relief, and overall health support, catering to a broad consumer base across diverse applications. Innovations in product formulations, delivery technologies, and functional applications further enhance efficacy and consumer acceptance. Leading companies such as Charlotte’s Web Holdings, Inc., CV Sciences, Inc., Medical Marijuana, Inc., Elixinol Wellness Ltd, and Medterra CBD, LLC are expanding their global presence, contributing to market development. Overall, CBD consumer health products play a crucial role in advancing preventive healthcare and natural wellness adoption worldwide.

 

Our Reports:

https://www.sphericalinsights.com/reports/north-america-preclinical-in-vivo-imaging-market

https://www.sphericalinsights.com/reports/south-korea-bioherbicides-market

https://www.sphericalinsights.com/reports/south-korea-electric-motors-market

https://www.sphericalinsights.com/reports/type-4-hydrogen-cylinder-market

https://www.sphericalinsights.com/reports/united-kingdom-airport-systems-market

https://www.sphericalinsights.com/reports/united-states-home-appliance-market

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter